Clinical Trial Update: A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports a Phase II study evaluating a combination of bevacizumab, irinotecan, and capecitabine in patients with previously untreated metastatic co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)
• Xeloda (capecitabine)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED